| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | galactoside binding | 1.53e-08 | 9 | 68 | 4 | GO:0016936 | |
| GeneOntologyMolecularFunction | disaccharide binding | 1.31e-06 | 7 | 68 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 4.13e-05 | 20 | 68 | 3 | GO:0070492 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.49e-07 | 4 | 70 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 2.07e-06 | 8 | 70 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 1.24e-05 | 42 | 70 | 4 | GO:0043032 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1.65e-05 | 15 | 70 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.65e-05 | 15 | 70 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 2.46e-05 | 17 | 70 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 2.95e-05 | 18 | 70 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 3.49e-05 | 19 | 70 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 3.49e-05 | 19 | 70 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 4.09e-05 | 20 | 70 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 4.29e-05 | 114 | 70 | 5 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 4.77e-05 | 21 | 70 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 6.23e-05 | 63 | 70 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 8.94e-05 | 133 | 70 | 5 | GO:0032760 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 9.20e-05 | 26 | 70 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 1.03e-04 | 137 | 70 | 5 | GO:1903557 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 1.15e-04 | 28 | 70 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 1.42e-04 | 30 | 70 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 1.57e-04 | 31 | 70 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.57e-04 | 31 | 70 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.62e-04 | 151 | 70 | 5 | GO:0002832 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 1.66e-04 | 81 | 70 | 4 | GO:0043030 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.73e-04 | 32 | 70 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 1.90e-04 | 33 | 70 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | LGALS9C DRD2 MGAT3 RARRES2 LGALS9B TET1 CHRD LAMA5 SEMA3G MMP3 RREB1 FAM83H LGALS9 | 1.91e-04 | 1211 | 70 | 13 | GO:0030334 |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 2.29e-04 | 88 | 70 | 4 | GO:0032732 | |
| GeneOntologyBiologicalProcess | negative regulation of dopamine secretion | 2.36e-04 | 7 | 70 | 2 | GO:0033602 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 2.68e-04 | 37 | 70 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 2.90e-04 | 38 | 70 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | LGALS9C DRD2 MGAT3 RARRES2 LGALS9B TET1 CHRD LAMA5 SEMA3G MMP3 RREB1 FAM83H LGALS9 | 3.28e-04 | 1280 | 70 | 13 | GO:2000145 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.38e-04 | 40 | 70 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 3.38e-04 | 40 | 70 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 3.64e-04 | 41 | 70 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 3.64e-04 | 41 | 70 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | maintenance of location | 3.86e-04 | 396 | 70 | 7 | GO:0051235 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 3.91e-04 | 42 | 70 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 4.19e-04 | 43 | 70 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 4.33e-04 | 104 | 70 | 4 | GO:0071677 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | LGALS9C DRD2 MGAT3 RARRES2 LGALS9B TET1 CHRD LAMA5 SEMA3G MMP3 RREB1 FAM83H LGALS9 | 4.64e-04 | 1327 | 70 | 13 | GO:0040012 |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 4.80e-04 | 45 | 70 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 5.12e-04 | 46 | 70 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 5.45e-04 | 47 | 70 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 5.45e-04 | 47 | 70 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 5.73e-04 | 112 | 70 | 4 | GO:0045185 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 5.80e-04 | 48 | 70 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 6.17e-04 | 49 | 70 | 3 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 6.17e-04 | 49 | 70 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.33e-04 | 115 | 70 | 4 | GO:0090100 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 6.94e-04 | 51 | 70 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 7.34e-04 | 52 | 70 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 7.34e-04 | 52 | 70 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 7.77e-04 | 53 | 70 | 3 | GO:0046640 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 7.77e-04 | 53 | 70 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 7.90e-04 | 122 | 70 | 4 | GO:0032755 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 8.03e-04 | 214 | 70 | 5 | GO:1903531 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 8.20e-04 | 54 | 70 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | negative regulation of transport | 8.21e-04 | 587 | 70 | 8 | GO:0051051 | |
| GeneOntologyBiologicalProcess | regulation of chemokine production | 8.65e-04 | 125 | 70 | 4 | GO:0032642 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 8.65e-04 | 125 | 70 | 4 | GO:0043279 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 9.12e-04 | 56 | 70 | 3 | GO:2000404 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 1.06e-03 | 59 | 70 | 3 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor production | 1.11e-03 | 230 | 70 | 5 | GO:0032680 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.15e-03 | 347 | 70 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | chemokine production | 1.15e-03 | 135 | 70 | 4 | GO:0032602 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 1.17e-03 | 61 | 70 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor superfamily cytokine production | 1.24e-03 | 236 | 70 | 5 | GO:1903555 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor production | 1.27e-03 | 237 | 70 | 5 | GO:0032640 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 1.28e-03 | 63 | 70 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.31e-03 | 239 | 70 | 5 | GO:0050777 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 1.31e-03 | 239 | 70 | 5 | GO:0051048 | |
| GeneOntologyBiologicalProcess | macrophage activation | 1.32e-03 | 140 | 70 | 4 | GO:0042116 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 1.34e-03 | 64 | 70 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor superfamily cytokine production | 1.41e-03 | 243 | 70 | 5 | GO:0071706 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte chemotaxis | 1.42e-03 | 143 | 70 | 4 | GO:0002688 | |
| GeneOntologyBiologicalProcess | adenohypophysis development | 1.49e-03 | 17 | 70 | 2 | GO:0021984 | |
| GeneOntologyCellularComponent | extracellular matrix | LGALS9C MXRA5 RARRES2 LGALS9B ANXA6 LAMA5 MMP3 MMP8 LGALS4 LGALS9 | 7.11e-05 | 656 | 71 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LGALS9C MXRA5 RARRES2 LGALS9B ANXA6 LAMA5 MMP3 MMP8 LGALS4 LGALS9 | 7.29e-05 | 658 | 71 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LGALS9C MXRA5 RARRES2 LGALS9B ANXA6 LAMA5 MMP8 LGALS4 LGALS9 | 7.45e-05 | 530 | 71 | 9 | GO:0062023 |
| MousePheno | lymph node hyperplasia | 9.31e-06 | 33 | 57 | 4 | MP:0008102 | |
| MousePheno | enhanced humoral immune response | 4.20e-05 | 17 | 57 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 5.95e-05 | 19 | 57 | 3 | MP:0008086 | |
| MousePheno | increased spleen germinal center size | 1.07e-04 | 23 | 57 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 1.07e-04 | 23 | 57 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 1.22e-04 | 24 | 57 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 1.39e-04 | 25 | 57 | 3 | MP:0002346 | |
| Domain | Gal-bind_lectin | 1.89e-07 | 15 | 66 | 4 | PF00337 | |
| Domain | Gal-bind_lectin | 1.89e-07 | 15 | 66 | 4 | SM00908 | |
| Domain | GALECTIN | 1.89e-07 | 15 | 66 | 4 | PS51304 | |
| Domain | Galectin_CRD | 1.89e-07 | 15 | 66 | 4 | IPR001079 | |
| Domain | GLECT | 1.89e-07 | 15 | 66 | 4 | SM00276 | |
| Domain | - | 2.14e-05 | 95 | 66 | 5 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.23e-04 | 219 | 66 | 6 | IPR013320 | |
| Domain | CUB_dom | 1.08e-03 | 57 | 66 | 3 | IPR000859 | |
| Domain | Pept_M10A_Zn_BS | 1.25e-03 | 15 | 66 | 2 | IPR021158 | |
| Domain | Hemopexin_CS | 1.62e-03 | 17 | 66 | 2 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 1.81e-03 | 18 | 66 | 2 | IPR016293 | |
| Domain | PG_binding_1 | 2.24e-03 | 20 | 66 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 2.24e-03 | 20 | 66 | 2 | IPR002477 | |
| Domain | CRAL_TRIO | 2.47e-03 | 21 | 66 | 2 | PF00650 | |
| Domain | Hemopexin-like_dom | 2.97e-03 | 23 | 66 | 2 | IPR000585 | |
| Domain | - | 2.97e-03 | 23 | 66 | 2 | 3.40.525.10 | |
| Domain | Hemopexin-like_repeat | 2.97e-03 | 23 | 66 | 2 | IPR018487 | |
| Domain | M10A_MMP | 2.97e-03 | 23 | 66 | 2 | IPR033739 | |
| Domain | Hemopexin | 2.97e-03 | 23 | 66 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 2.97e-03 | 23 | 66 | 2 | PS00024 | |
| Domain | - | 2.97e-03 | 23 | 66 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.97e-03 | 23 | 66 | 2 | PS51642 | |
| Domain | HX | 2.97e-03 | 23 | 66 | 2 | SM00120 | |
| Domain | Pept_M10A | 2.97e-03 | 23 | 66 | 2 | IPR021190 | |
| Domain | Peptidase_M10 | 3.23e-03 | 24 | 66 | 2 | PF00413 | |
| Domain | SEC14 | 3.50e-03 | 25 | 66 | 2 | SM00516 | |
| Domain | Bromodomain_CS | 3.78e-03 | 26 | 66 | 2 | IPR018359 | |
| Domain | CRAL_TRIO | 4.08e-03 | 27 | 66 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 4.38e-03 | 28 | 66 | 2 | IPR001251 | |
| Domain | ZnMc | 4.70e-03 | 29 | 66 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 4.70e-03 | 29 | 66 | 2 | IPR006026 | |
| Domain | ZINC_PROTEASE | 5.05e-03 | 98 | 66 | 3 | PS00142 | |
| Domain | - | 6.79e-03 | 35 | 66 | 2 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 7.17e-03 | 36 | 66 | 2 | IPR015422 | |
| Domain | BROMODOMAIN_1 | 7.56e-03 | 37 | 66 | 2 | PS00633 | |
| Domain | Bromodomain | 7.97e-03 | 38 | 66 | 2 | PF00439 | |
| Domain | - | 8.38e-03 | 39 | 66 | 2 | 3.40.640.10 | |
| Pubmed | 1.69e-11 | 4 | 72 | 4 | 11839756 | ||
| Pubmed | 2.52e-10 | 6 | 72 | 4 | 8674632 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 5.88e-10 | 7 | 72 | 4 | 8873770 | |
| Pubmed | 1.17e-09 | 8 | 72 | 4 | 23751344 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 8.51e-09 | 3 | 72 | 3 | 29458010 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 19776007 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 26582205 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 9153289 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 33316546 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 18974023 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 9038233 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 8.51e-09 | 3 | 72 | 3 | 29651447 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 28704475 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 21146220 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 8.51e-09 | 3 | 72 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 8.51e-09 | 3 | 72 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 8.51e-09 | 3 | 72 | 3 | 28990062 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 32380082 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 23667648 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 18579572 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 28877989 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 19800850 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 38987795 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 16990264 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 18005988 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 23585851 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 8.51e-09 | 3 | 72 | 3 | 29433546 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 37105392 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 36479526 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 8.51e-09 | 3 | 72 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 8.51e-09 | 3 | 72 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 8.51e-09 | 3 | 72 | 3 | 25898318 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 31937306 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 8.51e-09 | 3 | 72 | 3 | 31969388 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 8.51e-09 | 3 | 72 | 3 | 35241678 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 24083426 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 8.51e-09 | 3 | 72 | 3 | 25931247 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 22627368 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 33153471 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 22052881 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 17560833 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 8.51e-09 | 3 | 72 | 3 | 23408620 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 38686388 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 22677125 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 19234217 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 35715604 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 19017954 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 3.40e-08 | 4 | 72 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 3.40e-08 | 4 | 72 | 3 | 36459823 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 33107565 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 3.40e-08 | 4 | 72 | 3 | 29611821 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 30763585 | ||
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 3.40e-08 | 4 | 72 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 3.40e-08 | 4 | 72 | 3 | 19362679 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 25578313 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 3.40e-08 | 4 | 72 | 3 | 20463811 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 3.40e-08 | 4 | 72 | 3 | 23657851 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 18826117 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 24333756 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 38853593 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 3.40e-08 | 4 | 72 | 3 | 24958847 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 30120235 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 3.40e-08 | 4 | 72 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 3.40e-08 | 4 | 72 | 3 | 18346632 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 19670381 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 3.40e-08 | 4 | 72 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 3.40e-08 | 4 | 72 | 3 | 34369876 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 33203936 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 3.40e-08 | 4 | 72 | 3 | 22021615 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 29242193 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 8.48e-08 | 5 | 72 | 3 | 34847625 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 22469568 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 25158758 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 8.48e-08 | 5 | 72 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 8.48e-08 | 5 | 72 | 3 | 9566950 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 26278059 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 37352334 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 8.48e-08 | 5 | 72 | 3 | 37884694 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 21385853 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 1.69e-07 | 6 | 72 | 3 | 20937702 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 23296703 | ||
| Pubmed | Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. | 2.03e-07 | 121 | 72 | 6 | 8827514 | |
| Pubmed | 2.86e-07 | 27 | 72 | 4 | 36197846 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 31661141 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 36883358 | ||
| Pubmed | 6.60e-07 | 33 | 72 | 4 | 23118208 | ||
| Cytoband | 3p21.3 | 1.13e-04 | 59 | 72 | 3 | 3p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 2.04e-03 | 159 | 72 | 3 | chr7q36 | |
| Cytoband | 11q22.3 | 2.20e-03 | 44 | 72 | 2 | 11q22.3 | |
| Cytoband | 19q13.2 | 2.23e-03 | 164 | 72 | 3 | 19q13.2 | |
| Cytoband | 12q24.33 | 2.61e-03 | 48 | 72 | 2 | 12q24.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 3.13e-03 | 185 | 72 | 3 | chr7q34 | |
| GeneFamily | Galectins | 5.84e-08 | 15 | 48 | 4 | 629 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 1.84e-03 | 24 | 48 | 2 | 891 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.91e-06 | 158 | 72 | 6 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 7.47e-06 | 170 | 72 | 6 | M5880 | |
| Coexpression | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN | 9.29e-06 | 48 | 72 | 4 | M4655 | |
| Coexpression | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN | 1.85e-05 | 57 | 72 | 4 | MM807 | |
| Coexpression | NABA_MATRISOME | LGALS9C TMPRSS15 MXRA5 LGALS9B ANXA6 CHRD LAMA5 SEMA3G MMP3 MMP8 LGALS4 LGALS9 | 2.14e-05 | 1026 | 72 | 12 | M5889 |
| Coexpression | AFFAR_YY1_TARGETS_UP | 2.98e-05 | 217 | 72 | 6 | MM1156 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | LGALS9C TMPRSS15 LGALS9B ANXA6 CHRD SEMA3G MMP3 MMP8 LGALS4 LGALS9 | 3.27e-05 | 738 | 72 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | LGALS9C TMPRSS15 LGALS9B ANXA6 CHRD SEMA3G MMP3 MMP8 LGALS4 LGALS9 | 3.79e-05 | 751 | 72 | 10 | M5885 |
| Coexpression | NABA_MATRISOME | LGALS9C TMPRSS15 LGALS9B ANXA6 CHRD LAMA5 SEMA3G MMP3 MMP8 LGALS4 LGALS9 | 9.09e-05 | 1008 | 72 | 11 | MM17056 |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.34e-07 | 194 | 72 | 6 | 1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.56e-07 | 195 | 72 | 6 | 3365768101454060b9ea96ef6b426c76c150bc8f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 182 | 72 | 5 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 188 | 72 | 5 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.35e-05 | 188 | 72 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 188 | 72 | 5 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.38e-05 | 189 | 72 | 5 | bed43041e6f8ba19787150a6aaa492f2656135d9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 189 | 72 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 191 | 72 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 197 | 72 | 5 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late-42|World / Primary Cells by Cluster | 1.69e-05 | 197 | 72 | 5 | 0057aa4bce8684711b061710eab1d2b85e14e055 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late|World / Primary Cells by Cluster | 1.69e-05 | 197 | 72 | 5 | 9a65a54e097947601d8e382c4f4b4f5c2c1df51c | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 198 | 72 | 5 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 198 | 72 | 5 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 199 | 72 | 5 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-05 | 199 | 72 | 5 | 74fe1737a0d63ef0bc49312f1b5823b5c39590dd | |
| ToppCell | medial-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-05 | 199 | 72 | 5 | 8ce0bcc53b3a955285d614459e45210104a6ed02 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(50)_cDC2|Caecum / shred on region, Cell_type, and subtype | 1.77e-05 | 199 | 72 | 5 | bf8a10a9db7e8e0a6e2b53747949f442fe0e581e | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-05 | 199 | 72 | 5 | 263603264ff40ea8ef569cb43f8b84b5938438ab | |
| ToppCell | Caecum-Dendritic_cell-cDC2|Caecum / Region, Cell class and subclass | 1.77e-05 | 199 | 72 | 5 | 944c567307082dd54dc141e93965d46f4ec8bc1f | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 200 | 72 | 5 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-05 | 126 | 72 | 4 | 54247ce9ee0a4f123f1fb225600a4ec698510a86 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.06e-05 | 131 | 72 | 4 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.63e-05 | 139 | 72 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.63e-05 | 139 | 72 | 4 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 8.06e-05 | 141 | 72 | 4 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.72e-05 | 148 | 72 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 157 | 72 | 4 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 157 | 72 | 4 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.55e-04 | 167 | 72 | 4 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 171 | 72 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 171 | 72 | 4 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 172 | 72 | 4 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 172 | 72 | 4 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 67 | 72 | 3 | 52f6c244e8d89ccacb79bc5ef3663a5d01fd393c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 67 | 72 | 3 | e462f9b5dca7c64101a31891f25654c05f2d215d | |
| ToppCell | COVID-matDC-|COVID / Condition, Cell_class and T cell subcluster | 1.85e-04 | 175 | 72 | 4 | db5e170411dfa62074c4b8311bb8c589d1c4279b | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-04 | 175 | 72 | 4 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | COVID-matDC|COVID / Condition, Cell_class and T cell subcluster | 1.85e-04 | 175 | 72 | 4 | e2b638109c9ffd10430e6e134035622b7605ce23 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-04 | 176 | 72 | 4 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 177 | 72 | 4 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.93e-04 | 177 | 72 | 4 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 1.98e-04 | 178 | 72 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 178 | 72 | 4 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 180 | 72 | 4 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.06e-04 | 180 | 72 | 4 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 180 | 72 | 4 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 2.15e-04 | 182 | 72 | 4 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | Club-club-8|World / Class top | 2.15e-04 | 182 | 72 | 4 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 183 | 72 | 4 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 183 | 72 | 4 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 184 | 72 | 4 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-04 | 184 | 72 | 4 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-04 | 185 | 72 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 2.29e-04 | 185 | 72 | 4 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-04 | 186 | 72 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.34e-04 | 186 | 72 | 4 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-04 | 186 | 72 | 4 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-04 | 187 | 72 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 2.38e-04 | 187 | 72 | 4 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.43e-04 | 188 | 72 | 4 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 188 | 72 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 2.43e-04 | 188 | 72 | 4 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-04 | 188 | 72 | 4 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 2.43e-04 | 188 | 72 | 4 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 190 | 72 | 4 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.58e-04 | 191 | 72 | 4 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-04 | 192 | 72 | 4 | f345b269c8cf06b004bc9419462dbc69bffaab89 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 2.64e-04 | 192 | 72 | 4 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.64e-04 | 192 | 72 | 4 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-34|World / Primary Cells by Cluster | 2.69e-04 | 193 | 72 | 4 | d55f792eb3db10452347681131e07e041348fd89 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-04 | 193 | 72 | 4 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-04 | 193 | 72 | 4 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.69e-04 | 193 | 72 | 4 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-04 | 193 | 72 | 4 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 2.74e-04 | 194 | 72 | 4 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 194 | 72 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 194 | 72 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 2.74e-04 | 194 | 72 | 4 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 2.74e-04 | 194 | 72 | 4 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.74e-04 | 194 | 72 | 4 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 195 | 72 | 4 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.80e-04 | 195 | 72 | 4 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 195 | 72 | 4 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | cda3681f032f740cb09c64c62b9153cb62dbb5d2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 196 | 72 | 4 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 196 | 72 | 4 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | f78951b460913866d092ba92af70ea76a2afa73e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | b55aa507429ddce89ad4f42ab6daeca2f34fd676 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 196 | 72 | 4 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | 69ad90a429af4dad5a45556544224001ebcb1607 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 2.85e-04 | 196 | 72 | 4 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.57e-05 | 195 | 68 | 6 | 6052_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 2.88e-05 | 199 | 68 | 6 | 2683_UP | |
| Drug | alpha-sulfone 35c | 5.25e-05 | 4 | 68 | 2 | CID011533203 | |
| Drug | alpha-sulfone 35d | 5.25e-05 | 4 | 68 | 2 | CID009954521 | |
| Drug | carbamoylphosphonic acid | 5.25e-05 | 4 | 68 | 2 | CID013879809 | |
| Drug | 3-hydroxypicolinic acid | 5.25e-05 | 4 | 68 | 2 | ctd:C049246 | |
| Drug | alpha-sulfone 35h | 5.25e-05 | 4 | 68 | 2 | CID011684849 | |
| Drug | alpha-sulfone 35a | 5.25e-05 | 4 | 68 | 2 | CID011633617 | |
| Drug | beta-sulfone 7f | 8.74e-05 | 5 | 68 | 2 | CID011526076 | |
| Drug | alpha-sulfone 27e | 8.74e-05 | 5 | 68 | 2 | CID011719408 | |
| Drug | MMP-3 inhibitor | 8.74e-05 | 5 | 68 | 2 | CID010549329 | |
| Drug | beta-sulfone 7e | 8.74e-05 | 5 | 68 | 2 | CID011641261 | |
| Drug | beta-sulfone 7b | 8.74e-05 | 5 | 68 | 2 | CID009867183 | |
| Drug | CTS-1027 | 8.74e-05 | 5 | 68 | 2 | CID003342298 | |
| Drug | CGS 25966 | 8.74e-05 | 5 | 68 | 2 | CID009821883 | |
| Drug | SC-276 | 8.74e-05 | 5 | 68 | 2 | CID009802768 | |
| Drug | alpha-sulfone 35g | 8.74e-05 | 5 | 68 | 2 | CID011705502 | |
| Drug | beta-sulfone 7d | 8.74e-05 | 5 | 68 | 2 | CID011548264 | |
| Drug | alpha-sulfone 27d | 8.74e-05 | 5 | 68 | 2 | CID011532911 | |
| Drug | alpha-sulfone 27g | 8.74e-05 | 5 | 68 | 2 | CID011561491 | |
| Drug | alpha-sulfone 27b | 8.74e-05 | 5 | 68 | 2 | CID011697282 | |
| Drug | beta-sulfone 7c | 8.74e-05 | 5 | 68 | 2 | CID011613649 | |
| Drug | prinomastat | 8.74e-05 | 5 | 68 | 2 | ctd:C113282 | |
| Disease | Myofibrillar Myopathy | 1.37e-04 | 8 | 66 | 2 | C2678065 | |
| Disease | semaphorin-3G measurement | 1.37e-04 | 8 | 66 | 2 | EFO_0802049 | |
| Disease | retinoic acid receptor responder protein 2 measurement | 2.19e-04 | 10 | 66 | 2 | EFO_0008274 | |
| Disease | chemerin measurement | 8.22e-04 | 19 | 66 | 2 | EFO_0004573 | |
| Disease | alcohol use disorder measurement | 1.36e-03 | 214 | 66 | 4 | EFO_0009458 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 1.67e-03 | 27 | 66 | 2 | EFO_0004629, EFO_0004630 | |
| Disease | Glioblastoma Multiforme | 2.00e-03 | 111 | 66 | 3 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FHFNGAAPLSLFPNF | 36 | Q66K41 | |
| FHPRYPLFASGSDDG | 671 | Q14137 | |
| SPGFQFSAQPRRFEH | 101 | Q96L91 | |
| SHPNDDKDSGFFPRN | 426 | P48751 | |
| DPRPFRNGFVIGNDF | 2226 | Q7Z407 | |
| NPCGHLFRTAGDQPF | 46 | Q9UIF8 | |
| GGQVFRPSHPFERFD | 736 | A7MBM2 | |
| AGEPGHSPADYLRFQ | 391 | Q9Y463 | |
| RGSIHDFPGFDPNQD | 11 | P08133 | |
| GFGARIPPNFEVSHD | 361 | O95741 | |
| SPFDGPNGILAHAFQ | 171 | P22894 | |
| FGPHAFAPTFADGFA | 146 | Q96IS3 | |
| ESDGFFHPEGQPQRL | 996 | Q96EV2 | |
| AGEDPHSFYFPGQFA | 141 | Q99969 | |
| PFHSPSRLFDQFFGE | 16 | P02511 | |
| RNELPNFFSDCGHFP | 381 | A0A1B0GVH7 | |
| HFFEDQLRGAGFGPQ | 111 | Q56VL3 | |
| GGLDDFRNHPFFEGV | 326 | Q6DT37 | |
| PGSDVAFHFNPRFDG | 56 | P56470 | |
| FEFPHPDARLGFEQA | 1451 | Q96PE2 | |
| SPGHRAGLEPFFDFI | 26 | Q9H8Y8 | |
| YVFLDHFPPGGRQDG | 271 | Q09327 | |
| TGFSGNDIAFHFNPR | 51 | Q6DKI2 | |
| RFLGPEIFFHPEFAN | 146 | Q9C0K3 | |
| TGFSGNDIAFHFNPR | 51 | Q3B8N2 | |
| TGFSGNDIAFHFNPR | 51 | O00182 | |
| PFTGPNFDHTFGNAS | 376 | P98073 | |
| TGGFFHKEEFRPNAP | 361 | P80404 | |
| REHGDFYPFDGPGNV | 166 | P08254 | |
| GFTFGNVPEHRTGPF | 951 | O43424 | |
| FQHFRAAFEGSPQLP | 401 | Q9Y239 | |
| PGFQFSAQPRRFEHG | 91 | Q6ZTU2 | |
| EGAFLPPHQGFHRFL | 131 | P15289 | |
| APDGPERHFRFNGAG | 356 | Q86UU5 | |
| LNPDAEGNPFDHFSA | 151 | Q86V85 | |
| AATPEGHAVRFGFNP | 881 | O15230 | |
| SPAGRFFQENAFGNP | 461 | Q7Z2Q7 | |
| QNRTRSFGHFPGPEF | 171 | Q8IWW6 | |
| FNRFQPFHGLFDGVP | 286 | Q96BZ4 | |
| RPVHFQGPADSFFGY | 36 | Q13797 | |
| PGPNHGITHFDNFGF | 266 | Q13698 | |
| EDTVFFHLPPRNGNG | 71 | Q8NBF6 | |
| HPRFFNQLFSGLDPH | 86 | Q9Y600 | |
| TPEELFNVFFGGHFP | 171 | Q9H819 | |
| QLFRVTDFFPHPGFN | 86 | Q9UKQ9 | |
| PFNGSDGKADRPHYN | 21 | P14416 | |
| EGLGFPSFLDPDRHF | 336 | Q6ZRV2 | |
| FPHFSEAPARQGFSF | 216 | Q96LW4 | |
| DGQFAFLIPNGAFAH | 226 | Q14469 | |
| GFDDSVGRNPQPSHF | 426 | Q8ND04 | |
| FNFGPHDNSSFGNPS | 146 | Q9Y3Y4 | |
| ERHSGNFPGRDSLPF | 41 | P78332 | |
| NFPGRDSLPFDFQGH | 46 | P78332 | |
| PFSDNHQSPFLEGNG | 1886 | Q8WUY3 | |
| SFPLLEQFAGDGFHA | 446 | Q6ZMQ8 | |
| FGHDLSQGPNPDFQL | 186 | O94903 | |
| NTQGFPLAPERGLFH | 511 | Q8NFU7 | |
| DPNTCFFEGQQRPHG | 701 | Q9H2X0 | |
| DSFPARFGGVHFVNQ | 211 | Q8IUQ0 | |
| EHNLFPGPIDNSGLF | 61 | Q13107 | |
| PFDPRVLFSAGHDGN | 476 | Q8WWQ0 | |
| PNVEPFLHGNSFDLG | 321 | Q8WU10 | |
| AFLEPQNGFLHRGPT | 861 | Q92766 | |
| GNPQDIHRQPGFAFS | 501 | Q15022 | |
| VHSGPFGQVFRPDNF | 76 | A6NNZ2 | |
| GGSNTLNFQFHDPAP | 41 | O60504 | |
| RGNFPDQFSGHQFPN | 76 | A0A0A0MS05 | |
| RGNFPDRFSGHQFPN | 76 | A0A599 | |
| EVFNGPFAHRDGPQH | 351 | Q9NS98 | |
| LLPAGADFFGFSHPA | 286 | Q3YBR2 | |
| FLGQHGFNFFPSGID | 116 | Q9Y5A9 | |
| FFHPGYPRAVNFGAA | 561 | P23276 | |
| PSQFLHGNLFVFPNG | 2091 | Q9NR99 |